Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer

NCT00466232 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT00466232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00466232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
Lead sponsor
HealthPartners Institute
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2007
Completion date
March 31, 2010
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, small cell carcinoma